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Objective: To investigate the association between EVT start time in acute ischemic 
stroke (AIS) and mid-term functional outcome. 
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Methods: This retrospective cohort study included all AIS cases treated with EVT 
from two stroke center registries from January 2012 to December 2018. The primary 
outcome was the score on the modified Rankin Scale (mRS) and the utility-weighted 
mRS (uw-mRS) at 90 days. A proportional odds model was used to calculate the 
common odds ratio as a measure of the likelihood that the intervention at a given EVT 
start time would lead to lower scores on the mRS (shift analysis).  
 
Results: One thousand five hundred fifty-eight cases were equally allotted into twelve 
EVT-start-time periods. The primary outcome favored EVT start times in the morning 
at 08:00-10:20 and 10:20-11:34 (common odds ratio (OR), 0.53; 95% confidence 
interval (CI), 0.38 to 0.75; P<0.001; OR, 0.62; 95% CI, 0.44 to 0.87; P=0.006, 
respectively), while it disfavored EVT start times at the end of the working day at 
15:55-17:15 and 18:55-20:55 (OR, 1.47; 95% CI, 1.03 to 2.09; P=0.034; OR, 1.49; 
95% CI, 1.03 to 2.15; P=0.033). Symptom onset-to-EVT start time was significantly 
higher and use of IV t-PA significantly lower between 10:20-11:34 (P<0.004 and 
P=0.012, respectively). 
 
Conslusion: EVT for AIS in the morning leads to better mid-term functional 
outcome, while EVT at the end of the work day leads to poorer mid-term functional 
outcome. Neither difference in baseline factors, standard workflow and technical 
efficacy metrics could be identified as potential mediators of this effect.  
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Introduction 
Research on occupational accidents indicates that the risk of accidents while working 
increases as a function of number of hours at work.1-3 Hänecke and colleagues 
reported an exponential increase in occupational accidents after the ninth hour of 
work.4 Although most countries officially define the workday as eight hours, many 
doctors experience working hours well-beyond nine hours due to the need of 24-hour 
patient-care coverage.5, 6 Neurointerventionists and the rest of the stroke management 
team are currently feeling the effects of the changes in acute ischemic stroke (AIS) 
management,7 due in part to the mounting level of evidence from several large 
randomized controlled studies since 2015 that demonstrated the value of endovascular 
therapy (EVT) for first-line and delayed treatment.8-17 The significant increase in the 
number of EVT-eligible patients has proportionally increased the emergency case-
load for the neurointerventionists as well as the whole support staff in the stroke unit 
which extends the number of hours at work and could be a potential source of 
fatigue.18 The need to examine the effects of doctor fatigue on the mid-term outcome 
of treated patients was recognized and reported in the literature.19 Current data on 
mid-term functional outcome in patients treated during work hours versus after hours 
is limited requiring more robust studies to elucidate the effects on patients treated at 
different times of the day.20 We sought to investigate the association between EVT 
performed by presumed fatigued neurointerventionists and the stroke unit staff after 
standard working hours and the mid-term neurological outcome in treated patients.  
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Methods 
Patient population:  
We used two institutional databases, the acute stroke registry and analysis of 
Lausanne (ASTRAL) from Lausanne University hospital, Switzerland and the stroke 
registry from University Hospital of Bern, Bern, Switzerland; to retrospectively 
include all adult AIS patients who received EVT, either as thromboaspiration and/or 
mechanical thrombectomy according to institutional guidelines, from January 2012 to 
December 2018. For patient selection, we used the following inclusion criteria: AIS 
secondary to a large vessel intracranial occlusion, CT-based multimodal imaging 
performed within 24 hours of last proof of good health showing occlusion of an 
intracranial vessel amendable to EVT, brain angiography of good quality showing 
results following recanalization. Extracranial internal carotid artery occlusion or 
symptomatic stenosis without intracranial occlusion were excluded.  
Both hospitals feature a comprehensive stroke center accredited by the Swiss 
Federation of Clinical Neurosocieties Swiss Stroke Committee mainly based on 
recommendations of the Swiss Stroke Society and European Stroke Organisation. 
Stroke team composition was similar among both centers and included an onsite 
neurologist trainee, on-call stroke attending neurologist, onsite attending 
anesthesiologist, and on-call attending interventional neurologist at all times including 
standard working hours, nighttime, and weekends. Imaging protocol and EVT criteria 
were based on local institutional guidelines and were applied in the same way 
regardless of admission day or time. For the University Hospital of Bern, MRI is 
performed during night and daytime and there are no differences in its availability. 
Indications for EVT are standardized according to an institutional operating procedure 
scheme. For Lausanne University Hospital, a dedicated emergency MR imager is 
available 24 hours a day, 7 days a week. It prioritizes stroke cases and there are no 
differences in its availability during nighttime and weekends relative to daytime. 
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Indications for EVT are identical to those mentioned in the operating procedures of 
University Hospital of Bern. Transfer patients were generally not re-imaged unless 
transfer times were greater than 1.5 hours or the patient severely deteriorated after 
thrombolysis.  In these two situations, perfusion-CT/MRI was repeated prior to EVT. 
Both centers have between four and six interventional neuroradiologists in order to 
provide one on-call physician per center working in 24-hour shifts covering five to 
seven days per month. Approximately five EVTs are performed at Lausanne 
University and seven at University Hospital of Bern per week. During EVT, operators 
work almost exclusively independently with one angiography-suite technician 
working in eight-hour shifts providing technical and material support. Endovascular 
trainees are oftentimes present during EVT, but do not participate as primary or 
secondary operators. Finally, a wide array of stent retriever devices are used in these 
centers to perform EVT including, but not limited to Trevo (Stryker, Kalamazoo, 
Michigan, USA), Solitaire (Medtronic, Irvine, California, USA), Embotrap 
(Cerenovus, Galway, Ireland), Catch (Balt Extrusion, Montmorency, France) and 
Tiger (Rapid Medical, Yokneam, Israel).  
 
Data collection: 
Stroke-time onset and/or last time seen without symptoms, groin puncture-time and 
recanalization time were recorded for each patient. The EVT start time was 
considered the operator’s groin-puncture-time. A disproportionate number of EVTs 
were performed during normal working hours, making analysis at fixed time intervals 
with unequal cohort sizes a potential source of bias. As a result, patients were divided 
into twelve cohorts containing the same number of patients according to EVT start 
time, beginning at 08:00, the start of the work day, until 07:59 the following day. 
Time periods varied between cohorts, with those during the day shorter and those at 
night longer. To perform a multivariate analysis and eliminate confounding factors, 
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the following patient characteristics were recorded: age, sex, atrial fibrillation, 
smoking, diabetes, hypertension, and hyperlipidemia, as well as stroke characteristics 
including, National Institutes of Health Stroke Scale (NIHSS) score at admission, pre-
stroke modified Rankin Scale score (mRS), Alberta stroke program early CT score 
(ASPECTS), occlusion site, pre-stroke utility-weighted modified Rankin Scale score 
(uw-mRS), concomitant iv t-PA (tissue plasminogen activator), Trial of ORG 10172 
in Acute Stroke Treatment (TOAST) mechanism type, symptom onset-to-EVT start 
time, admission-to-EVT start time and occlusion site; defined as: 1-Large-artery 
atherosclerosis, 2-Cardioembolism, 3-Small-vessel occlusion, 4-Stroke of other 
determined aetiology, and 5-Stroke of undetermined etiology.21 The EVT 
characteristics reported included the following: modified treatment in cerebral 
ischemia (mTICI) score, number of EVT passes, symptomatic intracranial 
haemorrhage (sICH), and uw-mRS at 90 days post-EVT.22, 23 
 
Primary and secondary outcomes:  
The primary outcome of the study was the score on the modified Rankin scale at 90 
days after EVT, which was assessed by trained personnel who were unaware of the 
EVT start time. The modified Rankin scale is a graded interval scale (range, 0 [no 
symptoms] to 6 [death]) for the assessment of neurologic functional disability. 
Secondary outcomes included EVT start-to-recanalization interval time, mTICI score, 
number of EVT passes, and rate of sICH. 
 
Statistical analyses: 
Our analyses were performed to detect a shift in the distribution of scores on the 
modified Rankin scale at 90 days between each EVT time start time, with scores of 5 
(bedbound with severe disability) and 6 (death) combined due to comparable patient-
centered outcome and with the assumption that the differential effect would lead to a 
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common odds ratio (indicating the odds of improvement of 1 point on the modified 
Rankin scale) of 0.6 for positive effects and 1.4 for negative effects.24 
Comparisons of baseline characterisitics between cohorts were conducted using a 
one-way ANOVA for continuous variables of interest (age, NIHSS at admission, 
onset-to-EVT start time, number of EVT passes, baseline, EVT start-to-recanalization 
time, and uw-mRS at 90 days). Chi-square analysis was conducted for categorical 
variables of interest (atrial fibrillation, hypertension, smoking, diabetes, 
hyperlipidaemia, intravenous t-PA, TOAST, baseline, mTICI, and sICH). Continuous 
variables were presented using mean and interquartile range (IQR). Categorical 
variables were presented as frequencies with percentages. Significance was set at p 
<0.05. 
 
Detection of statistically significant variables was performed by a univariate analysis 
using an unpaired t-test comparing one cohort to all other reference cohorts, then 
subsequently repeated for other cohorts. Significance was set at p <0.05.  
Adjusted estimates of effect were selected according to clinical relevance and 
adjusted for age, symptom onset-to-EVT start time, age, NIHSS score, mTICI score, 
hypertension, and pre-stroke modified Rankin Scale score. The assessment of 
heterogeneity of EVT start time effect was performed with the inclusion of 
multiplicative interaction terms. Significance was set at p <0.05.  
 
Statistical analyses were performed using Anaconda version 5.3.1 (Anaconda, Austin, 
Texas, United States) for Python 2.7 (PSF, Delaware, United States) linked via 
module Rpy2 with R version 3.5.1ci (R Foundation, Vienna, Austria). For the primary 
endpoint, an ordinal multivariate logistic regression was performed with proportional 
odds ratio. To perform it, a Vector Generalized Linear and Additive Models 
(VGLM/VGAM) library was used in R. The confounding factors added into the 
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model were selected by clinical relevance. Non-collinearity was verified using 
tolerance metric in the R package  ‘olsrr.' All variables had a tolerance greater than 
0.2 with the lowest tolerance calculated at 0.23. This confirmed our clinical 
assumption of no collinearity between variables. 
 
Standard Protocol Approvals, Registrations, and Patient Consents: 
The study was approved by the local institutional review board of each hospital under 
the auspices of the Swiss ethics committees for research involving humans 
(Swissethics). No informed consent was required according to the legislation.  
 
Data Availability: 
Individual deidentified participant data, related documents such as study protocol, and 
statistical analysis will be shared on request from any qualified investigator for three 
years after the date of publication. 
 
Results 
A total of 1,574 EVT consecutive procedures meeting selection criteria were selected 
for review, with 991 cases derived from University Hospital of Bern of which 660 
were direct presentations (66%) and 581 from Lausanne University Hospital of which 
490 were direct presentations (83%). Sixteen cases were lost on follow-up as no 
information on mid-term functional neurological status was available. The 1,558 
cases available for analysis were distributed according to EVT start time into equal 
size patient-cohort time periods, each containing 127 to 131 patients. The cohorts 
were as follows: 08:00-10:20, 10:20-11:34, 11:34-12:40, 12:40-13:37, 13:37-14:41, 
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Demographics, cardiovascular risk factors, and stroke characteristics: 
A description of the demographics and cardiovascular risk factors for each patient 
cohort is shown in table 1. In summary, no inhomogeneity was detected in patient 
cohorts relating to demographics and cardiovascular risk factors with the exception of 
age; a small, yet statistically significant younger population was observed in the 
morning 08:00-10:20 cohort (P=0.002). The absolute difference of mean age between 
patients in this cohort relative to the mean of all patients included in the study was 3.5 
years. Additionally, fewer patients in this cohort were hypertensive (P=0.025). A 
description of stroke characteristics for each patient cohort is shown in table 2. Stroke 
characteristics were similarly homogenous with the exception of symptom onset-to-
EVT start time, IV t-PA use and admission-to-EVT start time. Onset-to-EVT start 
time was significantly longer between 10:20-11:34 and 02:07-07:58, while 
significantly shorter between 20:55-22:57 and 22:57-02:07 (P=0.004). Intravenous t-
PA was used less frequently between 10:20-11:34 and 02:07-07:58 (P=0.012). 
Admission-to-EVT start time was significantly longer between 02:07-07:58. A 
description of stroke occlusion site is shown in table 3. Distribution of stroke 
occlusion site was homogenous among all cohorts. 
 
Primary endpoint, EVT-start time and mid-term functional outcome: 
Table 4 describes the univariate and multivariate analyses investigating the 
relationship between the EVT-start time and mRS, uw-mRS and mortality at 90 days. 
Analysis of the primary end point showed a common odds ratio (indicating the odds 
of improvement of 1 point on the modified Rankin scale) of 0.53 (95% confidence 
interval [CI], 0.38 to 0.75, P<0.001) and of 0.62 (95% CI, 0.44 to 0.87, P=0.006) 
favoring EVT with start times in the morning at 08:00-10:20 and 10:20-11:34 as well 
as 1.47 (95% CI, 1.03 to 2.09, P=0.034) and 1.49 (95% CI, 1.03 to 2.15, P=0.033) at 
15:55-17:15 and 18:55-20:55, respectively, disfavoring EVT at start times at the end 
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of the work day. Figure 1 shows the effect size in the primary end point across all 
EVT start time cohorts. There was a higher uw-mRS at 90 days signifying better 
functional outcome in patients with EVT performed between 08:00-10:20 (5.9, 95% 
CI, 3.3 to 9.1, p<0.001) as well as EVT performed between 10:20-11:34 (5.2, 95% CI, 
0.0 to 9.1, p=0.008) and significantly lower uw-mRS signifying poorer functional 
outcome in patients treated at 15:55-17:15 (5.0, 95% CI, 0.0 to 8.4, p=0.017) 
P=0.017). Figure 2 depicts the uw-mRS at 90 days as a function of time-period cohort 
for both stroke centres. Similar trends in functional outcome are observed in each 
stroke centre.   
The proportion of patients with a modified Rankin score of 0 to 2 at 90 days was 
37.6% and 37.2% when EVT start times were between 08:00-10:20 and 10:20-11:34, 
respectively, while only 22.5% and 19.0% for EVT start times at 15:55 and 18:55-
20:55. Mortality at 90 days was lower in the morning in 12.8 % patients with EVT 
start time at 08:00-10:20 (OR: 0.52; 95% CI, 0.28 - 0.90); P = 0.028) and higher in at 
the end of the workday in 32.5% patients when EVT start times were 15:55-17:15 
(OR: 1.78; 95% CI, 1.21 - 2.79); P = 0.013) 
 
Secondary endpoints, EVT procedural characteristics:  
Table 5 describes the univariate analysis of EVT characteristics in all time-period 
cohorts. In summary, mTICI score, number of EVT passes, presence of sICH and 
EVT start-to-recanalization time were not significantly different.  
 
Discussion 
The main finding of the present study is that mid-term functional outcome and 
mortality after EVT in AIS varied according to the start time of thrombectomy. EVT 
performed in the morning, 08:00-10:15, yielded good functional outcomes, whereas 
EVT performed after the ninth hour of work, 15:55-17:15, lead to poorer functional 
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outcomes. Surprisingly, outcome from EVT performed at nighttime is not 
significantly worse than EVT performed during the day. The difference observed does 
not seem to be be caused neither by differences in baseline characteristics nor due to 
difference in standard measures of interventional efficacy and safety at different time 
points.   
 
Endovascular therapy is a procedure requiring a high degree of vigilance and reflex, 
developed after several years of specialized training that may become impaired due to 
extended working hours.25 Patients admitted out of normal work hours are less likely 
to be managed according to current operational guidelines leading to to poorer short-
term outcomes than those admitted during normal work hours.26 We hypothesized that 
EVT performed outside of the workday or at night would lead to poorer mid-term 
functional outcome because of doctor fatigue. The link between fatigue and 
performance remains controversial, with some studies failing to demonstrate any 
correlation between extended working hours worked and doctor performance or 
safety outcomes.27 A systematic literature review by Gates and colleagues suggests 
that evidence for possible association of doctor fatigue with performance is varied in 
part because of the use of heterogenous outcome measurements.19 In s roke 
management, the outcomes of interest are mid-term functionality graded on the mRS 
and uw-mRS, a patient-centred scale that measures benefit of a given intervention to 
the patient.23  We studied effect on mRS as a function of EVT-start time. Assuming 
that the on-call neurointerventionist begins his workday between 07:00 and 08:00, our 
study suggests that at the start of the workday, between 08:00-10:31, technical 
performance is optimal in a rested and vigilant doctor leading to the significantly 
higher uw-mRS at 90 days, or better mid-term functional outcome observed. 
However, the analyses of the secondary endpoints measuring technical performance 
did not reveal higher rates of complete recanalization, fewer numbers of EVT passes, 
 
Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.  
 
faster procedure times or lower rates of sICH. Notably, in this cohort, symptom onset-
to-EVT start times were significantly longer and on average beyond 4.5 hours. This 
may suggest that many patients in this cohort met the stricter EVT requirements and 
thus had relatively better collateral circulation and smaller core infarct sizes, which 
could be a potential source of selection bias. Any possible inhomegeinity between 
cohorts cannot be corroborated because these two stroke characterisitcs were not 
recorded in the majority of patients in the two institutional databases used in this 
study. We hypothesize that in the morning cohorts, an increased number of stroke 
patients of unknown onset with limited infarct core size due to good collateralization 
were selected for EVT and thus had a higher probability of favorable mid-term 
functional outcome. These patients were statistically younger than other cohorts thus 
had better leptomeningeal collateral circulation and better hemodynamic variables 
with hypothetically small core size volumes. This cannot be substantiated in this study 
because infarct volume size was not available for analysis in this dataset. 28, 29 Also, 
only 66.4% patients at 08:00-10:15 were hypertensive compared to a frequency of 
74.7% for all groups. While concomitant hypertension in AIS is associated with 
poorer outcome and therefore could in part explain better outcome in the morning 
cohorts, we do not observe a statistically poorer outcome in cohorts with higher 
frequency hypertension. Additionally, any inhomogeneity in rates of hypertension 
among the cohorts cannot solely explain, according to the applied statistical model, 
the difference in mid-term functional outcome.30 Moreover, this could also indicate 
that a large number of patients were deemed unsuitable, but possibly could of 
benefitted from EVT.  
Conversely, EVTs performed between 15:55-17:15, after a nine-hour workday, were 
associated with higher mRS at 90 days or poorer mid-term functional functional 
outcome. Although, our multivariate analysis showed significantly higher mRS at 90 
days, intermediate outcome measurements that have predictive effects on mid-term 
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functional outcome, like mTICI, number of EVT passes, rate of sICH were not 
significantly altered in this time period.31-33 Moreover, EVT start-to-recanalization 
time, a measure of technical skill, and rapidity, was not significantly different 
between time-period cohorts. We therefore hypothesize that other factors independent 
of doctor fatigue, such as stroke team shift changes or hampered performance from 
other collaborators such as emergency neurologist or support staff in the stroke unit, 
may contribute to poor functional outcome. Figure 3 shows the work shifts for 
interventional neuroradiology, stroke unit and emergency neurology physicians at 
both centers. 
Additionally, the observed outcome decline between 15:55-17:15 was only transient, 
with values of uw-mRS at 90 days actually increasing after 17:15, at the end of the 
standard work day in our two hospitals. Admission-to-groin puncture delay were 
significantly longer at night, which has been previously reported. 34, 35 Corroborating 
the findings of the MR CLEan Registry, this delay was not appreciable in our analysis 
regarding clinical outcome. We conjecture that working conditions for EVT 
paradoxically improves during the evening or night and may maintain good technical 
performance and offset fatigue partially because of less work burden and/or 
distractions. Studies on work-related injuries as a function of the number of hours 
worked, showed a transient, yet significant increase after the ninth hour of work, but a 
non significant risk thereafter or at nighttime.4, 36 The results of this study show 
similar findings regarding functional outcome and highlights similar trends in both 
stroke centres included in this study.  
Finally, the repercussions of the burgeoning demand for EVT due to recent paradigm 
shifts of AIS management on neurointerventionists and the stroke unit staff remains 
controversial.25 Previously, AIS stroke management was limited to IVT, requiring 
knowledge but not depending on technical skill. Nowadays, the complexities involved 
in EVT during AIS management, poses challenges to neurointerventionists, 
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anaesthetists, and stroke unit staff faced with increasing caseload, extended working 
hours, and more on-call duties. Our data show differences in outcome warranting 




One of the weaknesses of this study is that many of the confounding variables cannot 
be controlled in the analyses, such as variability in a doctor’s skill, training level or 
overall stroke-unit performance. For example, interruptions of activity related to shift 
changes, patient transferring, and diagnostic exams during the day may decrease the 
amount of time for direct patient care in certain cohorts leading to adverse effects 
prior to or following EVT. Any potential difference may also be observed between 
the hospitals included in this study as Lausanne University Hospital performs fewer 
EVTs than University Hospital of Bern. Nevertheless, the subgroup analysis of uw-
mRS at 90 days for each hospital reveals similar trends as a function of EVT-start 
time, most notably at 15:54-17:15. Moreover, the addition of center variables, such as 
hospital site or weekday versus weekend, to the logistic regression did not affect 
results. Additionally, perfusion imaging data and infarct core size score were not 
available for analysis and inhomogeneity in these characteristics among the cohorts 
may explain differences in clinical outcome. Other limitations include the fact that 
this study is retrospective and includes AIS patients treated by EVT from 2012, an era 
when EVT was less standardized.  
 
Conclusion 
EVT for AIS patients performed in the morning between 08:00-10:20 leads to better 
mid-term functional outcome at 90 days, despite having a statistically longer 
symptom onset-to-EVT start time delay, while EVT performed at the end of the 
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working day, between 15:54-17:15, leads to poorer neurological outcome. Additional 
prospective studies data are required to support our findings and futher analysis 
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Figure 1. Analysis of the Primary Endpoint. 
The forest plot shows the effect size in the primary endpoint (common odds ratio for 
improvement on the modified Rankin scale at 90 days, analyzed according to ordinal 
logistic regression and adjusted for age, symptom onset-to-EVT start time, age, 
National Institutes of Health Stroke Scale score, modified treatment in cerebral 
ischemia score, and pre-stroke modified Rankin Scale score) across all EVT start time 
cohorts.  
There are significant differences in the morning cohorts at 08:00-10:20 and 10:20-
11:34 suggesting better functional outcome at three months as well as in the end-of-
workday cohorts at 15:55-17:15 and 18:55-20:55 suggesting poorer functional 










Figure 2. Scores on the utility-weighted modified Rankin Scale at 90 days for 
each stroke center as a function of endovascular therapy start time. 
Data are organized into twelve equally-sized cohorts over 24 hours starting at 8:00. 
Higher scores indicated better functional outcome. Green shading corresponds to 
cohorts with favorable functional outcome at three months, while red shading 















Figure 3. Shift schedules for physicians in interventional neuroradiology (INR), 
stroke unit (SU) and emergency neurology (EN). 
Data are organized into twelve equally sized cohorts over 24 hours starting at 8:00. 
Green shading corresponds to cohorts with favorable functional outcome at three 
months, while red shading corresponds to cohorts with poorer functional outcome at 
three months.  
 
 




Table 1: Patient characteristics and cardiovascular risk factors 
 
 
Data are mean (IQR) or n (). a P value = 0.002, calculated using one-way ANOVA. b P value = 0.025, 



















































































































































































































































Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.  
 





































































































































TOASTd              0.197 
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Data are mean (IQR) or n (%). EVT=endovascular therapy. a Scores on the National Institutes of Health 
Stroke Scale (NIHSS) range from 0 to 42. Scores increase as a function of neurological deficit. b
Alberta Stroke Program Early CT Score (ASPECTS) ranging from 0 to 10. c Intravenous treatment with 
tissue plasminogen activator (t-PA) was used up to 4.5 hours after symptom onset. 1473 patients 
analyzed. d Trial of ORG 10172 in Acute Stroke Treatment (TOAST) classification of subtypes of 
acute ischemic stroke are defined as: 1-Large-arteryatherosclerosis, 2- Cardioembolism, 3- Small-
vessel occlusion, 4-Stroke of other determined etiology and 5-Stroke of undetermined etiology. 1505 
patients analyzed. e Scores on the modified Rankin scale: 0- no symptoms, 1- no clinically significant 
disability, 2- slight disability, 3- moderate disability, 4- moderately severe disability, 5- severe 
disability, 6- death. 1498 patients analyzed. fScore on utility-weighted modified Rankin scale (uw-
mRS) ranges from 0: death to 10: no symptoms or disability. g EVT=endovascular therapy. h The P 
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Table 3: Occlusion site 
 
Data are n (%). 1442 patients analyzed.  P value of 0.51 was calculated using -squared. a Patients who 
had occlusion of intracranial internal carotid artery (carotid terminus) may have also had thrombus 













































































































































































(7.2) 10 (8.2) 6 (4.9) 5 (4.2) 10 (8.2) 4 (3.4) 
14 









(0.4) 0 (0) 1 (0.8) 0 (0) 0 (0) 1 (0.9) 1 (0.9) 0 (0) 0 (0) 0 (0) 0 (0) 2 (1.7) 1 (0.8) 
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Table 4: Unadjusted and adjusted association between EVT start time and long-
term neurological outcome 
 
 
Data are mean (IQR) or n (%). a Scores on the modified Rankin scale range from 0 to 6, with 0 
indicating no symptoms, 1 no clinically significant disability, 2 slight disability, 3 moderate disability, 
4 moderately severe disability, 5 severe disability, and 6 death. Distribution of scores at 90 days for 
EVT start times in the overall trial population. b The utility-weighted modified Rankin scale ranges 
from 0 (death) to 10 (no symptoms or disability). c The measurement of effect was a cumulative 
logistic-regression odds ratio (shift analysis). d Controlling for age, symptom onset-to-EVT start time, 
age, National Institutes of Health Stroke Scale score, modified treatment in cerebral ischemia score, 
and pre-stroke modified Rankin Scale score. 
 
  
 Modified Rankin Scale score at 90 days
a Utility -weighted 
Modified 
Rankin Scale 
score at 90 daysb 
Reduction in Modified Rankin scale 
score at 90 daysc 
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0.51 (0.37-0.70)  
p<0.001 
0.53 (0.38-0.75)  
p<0.001 





















0.63 (0.46-0.88)  
p=0.006 
0.62 (0.44-0.87)  
p=0.006 





















1.03 (0.74-1.43)  
p=0.853 
0.76 (0.54-1.07)  
p=0.123 





















1.02 (0.73-1.42)  
p=0.919 
















































0.87 (0.62-1.21)  
p=0.407 
1.12 (0.78-1.59)  
p=0.539 





















1.46 (1.05-2.05)  
p=0.025 
1.47 (1.03-2.09)  
p=0.034 





















1.09 (0.79-1.52)  
p=0.596 
1.09 (0.77-1.54)  
p=0.629 





















1.42 (1.01-1.99)  
p=0.042 
1.49 (1.03-2.15)  
p=0.033 







































































1.28 (0.92-1.78)  
p=0.152 
1.15 (0.80-1.65)  
p=0.453 
1.02 (0.61-1.64)  
p=0.947 
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Data are mean (IQR) or n (%). a Modified Thrombolysis in Cerebral Ischemia (mTICI) score: 2b or 3 
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